tirzepatide surpass-5 Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial Latest Data From SURPASS Trials

(2) GIP and GLP-1 target overlapping but distinct hypothalamic circuitsGIP may augment satiety through the infundibular nucleus in ways complementary to GLP-1's arcuate nucleus effects

The fact that pricing was right there on the website made the decision easy

Behavioral Strategies : Identifying triggers for overeating and developing coping strategies can be beneficial

These effects typically resolve within 2-3 weeks as the body adjusts

Cyanocobalamin can also be prescribed to treat pernicious anemia, a condition where the body is unable to absorb sufficient amounts of vitamin B12 from food

Price is still a bit high for the product, imo Love the stuff